Thailand defends decision not to join Covax vaccine alliance

Spread the love

BANGKOK (REUTERS) – The Thai government on Sunday (Feb 14) defended its decision not to join the World Health Organisation-sponsored coronavirus vaccine programme, saying that to do so would risk the country paying more for the shots and facing uncertainty about delivery times.

The government has been criticised by opposition politicians and protesters for lacking transparency and being too slow in procuring vaccines.

While the country of 66 million people has had low numbers of cases and deaths, it is dealing with a second wave of infections.

Front-line health workers are to begin receiving 2 million imported Chinese Sinovac shots within a month, but mass vaccinations for the general population are not due to begin until locally produced AstraZeneca doses are ready in June.

Government spokesman Anucha Buraphachaisri, responding to media reports that Thailand is the only South-east Asian country to skip the World Health Organisation’s (WHO) Covax scheme, said that as a middle-income country, Thailand is not eligible for free or cheap vaccines under the programme.

“Buying vaccines directly from the manufacturers is an appropriate choice… as it’s more flexible,” Mr Anucha said.

“If Thailand wants to join the Covax programme, it will have to pay for vaccines itself with a high budget and there is also a risk,” he said, adding that the country had to make an advance payment without knowing the source of vaccines and delivery dates. He did not specify the costs.

In all, 190 countries have joined Covax, which aims to ensure equitable access to vaccines during the pandemic.

The scheme is jointly run by the GAVI alliance, the WHO, the Coalition for Epidemic Preparedness Innovations and Unicef.

Thailand so far has not received or produced any vaccines, even as many of its neighbours have started inoculations.

Thailand reported 166 new coronavirus cases on Sunday, taking its total number of infections to 24,571, with a death toll of 80.

Leave a Reply

Your email address will not be published. Required fields are marked *